Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
21
Frequently Asked Questions
What is Market Cap of Plus Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Plus Therapeutics Inc market cap is $44.4M.
What is the 52-week high for Plus Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Plus Therapeutics Inc 52 week high is $2.31 as of September 14, 2025.
What is the 52-week low for Plus Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Plus Therapeutics Inc 52 week low is $0.1634 as of September 14, 2025.
What is Plus Therapeutics Inc stock price today?
Plus Therapeutics Inc stock price today is $0.4473.
What was Plus Therapeutics Inc stock price yesterday?
Plus Therapeutics Inc stock price yesterday was $0.4699.
What is the PE ratio of Plus Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Plus Therapeutics Inc’s P/E ratio is -0.20.
What is the Price-to-Book ratio of Plus Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Plus Therapeutics Inc P/B ratio is 13.5916.
What is the 50-day moving average of Plus Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Plus Therapeutics Inc 50-day moving average is $0.4958.
How many employess does Plus Therapeutics Inc has?